RxDoctor Payments Data

Steven Repitor, DPM

Podiatrist · Sterling Heights, MINPI 1689601353

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,039 of the $5,515 with a category attached, or 73.2%. It is spread thinly across 36 manufacturers, the largest accounting for just 22.5%. Reporting peaked in 2021 at $1,947 and has fallen 88.9% since, to $216 in 2025.

$5,515in general payments, 2019–2025

Across 101 payments — averaging $54.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pinnacle, Inc$1K
  • Smith+Nephew$671
  • Bard Peripheral Vascular, Inc.$485
  • Inari Medical, Inc.$416
  • DJO, LLC$276
  • Stryker$263
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,03973%
  • Education$1,20022%
  • Other$2765%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,515 in reported general payments places this provider in the 80th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$157,292
Medicare patients
847
Services billed
3,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole163$5,326
CiclopiroxCiclopirox Olamine175$3,698
Ammonium Lactate35$501
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$359
Terbinafine Hcl26$315
Doxycycline Hyclate18$287
Meloxicam115$252
Celecoxib14$232
Gabapentin17$210
Nystatin14$184
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim46$178
Prednisone73$149
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$109
Naproxen19$81
Ciprofloxacin Hcl11$67

Paid to pharmacies, not to this prescriber.

Other podiatrist in Sterling Heights

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →